Real-world efficacy and safety of dupilumab for atopic dermatitis in a Hispanic population: A single-center retrospective cohort study

被引：0
|
作者：
Santiago-Vazquez, Marely [1 ]
Pelet, Natalia [2 ]
Cuesta, Jose M. [3 ]
Michelen, Eduardo [2 ]
Ramos, Alvaro J. [1 ]
Martin, Rafael F. [1 ]
机构：
[1] Univ Puerto Rico, Dept Dermatol, San Juan, PR USA
[2] Univ Puerto Rico, Transit Year Program, San Juan, PR USA
[3] VA Caribbean Healthcare Syst, San Juan, PR USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34201
引用
收藏
页码：AB199 / AB199
页数：1
相关论文
共 50 条
  • [1] Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective study
    Pirov, Eitan
    Molho-Pessach, Vered
    Cohen-Barak, Eran
    Levitt, Jen A. Barak
    Barzilai, Aviv
    Bar, Jonathan
    Renert-Yuval, Yael
    Bar-Ilan, Efrat
    Friedland, Rivka
    Greenberger, Shoshana
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [2] Real-World Efficacy and Safety of Dupilumab Use in Japanese Adult Patients with Atopic Dermatitis: A Single-Center, Retrospective, 104-Week, Observational Study
    Ikegami, Tetsuharu
    Igawa, Ken
    DISEASES, 2025, 13 (02)
  • [3] Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study
    Uchiyama, Akihiko
    Fujiwara, Chisako
    Inoue, Yuta
    Motegi, Sei-ichiro
    JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 469 - 471
  • [4] Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study
    Li, Zheng
    Wang, Yu
    Wu, Yuemeng
    Yin, Huibin
    Wang, Shangshang
    Wu, Hao
    Qin, Haihong
    Wang, Ce
    Yao, Xu
    Li, Wei
    Gu, Chaoying
    ALLERGY, 2025,
  • [5] Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
    Zhou, Bingjing
    Peng, Cong
    Li, Liqiao
    Liu, Runqiu
    Zhu, Lei
    Chen, Xiang
    Li, Jie
    FRONTIERS IN MEDICINE, 2022, 9
  • [6] Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population: Real-world data from a single center
    Yang, Zijing
    Wen, Wanting
    Shi, Ruofei
    Chen, Lihong
    Wang, Hailun
    Zheng, Jie
    Zhu, Haiqin
    Pan, Meng
    Zhao, Xiaoqing
    ALLERGY, 2024, 79 (05) : 1379 - 1382
  • [7] Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
    Jang, Dong Hyek
    Heo, Seok Jae
    Jung, Hye Jung
    Park, Mi Yeon
    Seo, Seong Jun
    Ahn, Jiyoung
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 12
  • [8] Dupilumab for atopic dermatitis treatment: A single-center retrospective study
    Yasar, Gulbin
    Bilgic, Asli
    Yilmaz, Ertan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2022, 56 (01): : 12 - 16
  • [9] Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States
    Emmerich, Veronica K.
    Williams, Josiah A.
    Hrin, Matthew L.
    Feldman, Steven R.
    Strowd, Lindsay C.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (04) : 524 - 525
  • [10] One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study
    Uchida, Hideaki
    Kamata, Masahiro
    Kato, Aika
    Mizukawa, Itsumi
    Watanabe, Ayu
    Agematsu, Ai
    Nagata, Mayumi
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Ohnishi, Takamitsu
    Tada, Yayoi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02) : 547 - 550
12345